Alveus raises $160M Series A for obesity drugs
Philadelphia VC firm creates obesity drug startup, raises $159.8M Series A
Alveus Therapeutics, a Philadelphia start-up treating obesity, debuted with $160M in funding
Alveus launches with $160M as newest start-up to step into obesity fray